Skip to content

ProHealth Longevity Review: Is NMN Pro the Benchmark?

ProHealth's NMN Pro is often called the NMN benchmark. Its lab report is real. The trial behind 'clinically studied' is a 66-person manufacturer study.

By Marcus HaleLongevity Research Editor
Updated

10 min read · 12 sources

On this page

ProHealth Longevity is the brand most often named when someone asks which NMN is the serious one. It has been selling supplements since 1988, it is the US seller of the branded raw material Uthever NMN, and unlike most of the shelf it publishes an actual product-specific lab report you can open and read. That combination is why roundups keep calling NMN Pro the benchmark, and it is why this review takes the brand seriously rather than lumping it in with the dozens of unmarked NMN bottles.

But "the best-documented NMN" is a claim about a low bar, and the documentation turns out to be thinner and more interested than the storefront suggests. We rechecked the NMN Pro 500 offer and purchase policies on October 15, 2026; the scientific discussion below distinguishes the ingredient trial from the product’s quality paperwork.

What ProHealth Longevity actually sells

The NMN line runs on Uthever NMN, a branded β-nicotinamide mononucleotide raw material. On October 15, 2026, the rendered store listed NMN Pro 500 (500 mg, 30 capsules) at $42.95 one-time, or $38.66 on a 10% subscription; NMN Pro 1000 (1,000 mg per serving, 60 capsules) at $64.95; and NMN Pro Powder (100 g) at $98.95. Around those sit tablets, lozenges, liposomal versions, bulk powders up to a kilo, an NMNH line, and blends that add trans-resveratrol and TMG.

That is a wide catalog, and two of its items matter enormously for how you should read this brand — we get to them below.

For context on the compound itself rather than the seller, start with does NMN actually work? and NMN vs NR.

Buying NMN Pro 500: cost, renewal and returns

The $42.95 one-time bottle contains 30 capsules and 30 servings of 500 mg: about $1.43 per day. The displayed subscription is $38.66 per bottle, about $1.29 per day, with a 10% discount. One-time purchase is available without a subscription. The seller says subscriptions can be paused or canceled through “Manage Subscriptions,” without commitments or cancellation fees; check the selected shipment interval before ordering. The page advertises free U.S. shipping over $30. These are displayed product prices, before any applicable tax. 10

The 100-day guarantee has conditions that the short product-page promise leaves out. ProHealth’s return policy requires the unused portion to be returned, refunds or credits product cost, and excludes shipping charges. For multipacks, only one bottle may have been opened. Opened bulk bags of 100 g, 250 g, 500 g or 1 kg are final sale. A small capsule bottle therefore gives a buyer more flexibility than committing to bulk powder just to lower the price per gram. 11

The uncomfortable part: what "clinically studied" is resting on

ProHealth's NMN collection page states the claim plainly: Uthever NMN "was shown to increase NAD⁺ levels by up to 38%—equivalent to reversing biological age by 12 years." The elevator version of the brand is built on that sentence. So we opened the study.

The trial is a 2022 paper in Frontiers in Aging 1. Here is what it is:

  • 66 participants, aged 40 to 65, for 60 days, taking two 150 mg capsules a day — so 300 mg daily, well below the 500 mg and 1,000 mg servings ProHealth sells most of.
  • It has one author, and that author's stated affiliation is Effepharm (Shanghai) Co., Ltd. — the company that makes Uthever NMN. The paper carries a conflict-of-interest statement to that effect.
  • What it measured was the serum NAD+/NADH ratio, not an absolute intracellular NAD+ concentration. The Uthever group's ratio rose 38% from baseline at day 60. The placebo group's ratio rose 14.3% over the same period, which tells you how much movement this measure has in it before anything is taken.
  • The other endpoints were an SF-36 quality-of-life score (6.5% vs 3.4% in placebo) and HOMA-IR.

And the part that matters most: the paper contains no biological-age measurement at all. There is no epigenetic clock, no aging biomarker panel, nothing that could produce a figure like "12 years." That number is not a finding being reported; it is an inference layered on top of a ratio, on a product page, by the company selling the product. A biomarker moving is not a birthday moving backward, and the study ProHealth cites did not test the difference. This is the single largest gap between what the marketing says and what the cited evidence contains.

Marketing vs. what we found

ProHealth saysWhat we found
Uthever NMN raises NAD+ up to 38%Manufacturer-run trial: serum NAD+/NADH ratio +38% at day 60 — placebo arm rose 14.3%
Equivalent to reversing biological age 12 yearsThe cited paper measured no biological-age endpoint at all
World's first clinically studied NMN brandOne study, 66 people, 60 days, single author employed by the ingredient maker
Triple Lab TestedOne published report, one lab, one analyte — but 513.21 mg vs a 500 mg claim
Injection delivers benefits fasterNo established faster routine wellness benefit for this injection
From ProHealth's own website, the Uthever trial and the Brighton Laboratory report, August 2026.

None of that makes Uthever bad material. It makes the phrase "the world's first clinically studied NMN brand" much smaller than it sounds: one manufacturer-run study, one author, 66 people, a ratio, two months.

What the independent evidence does support

Strip the brand away and the underlying compound has a real, reproducible effect — one that ProHealth is entitled to claim and that does not depend on Effepharm's study at all.

Oral NMN reliably raises blood NAD+ in humans. A dose-ranging randomized trial in healthy middle-aged adults found NMN raised blood NAD+ and was well tolerated across the doses tested 2. A controlled study found oral NMN safe and efficient at increasing blood NAD+ in healthy subjects 3, and a single-dose study in healthy men showed it is safely metabolized into NAD precursors 4. That is a genuinely better evidence base than the one ProHealth leans on, and it belongs to the molecule rather than to any seller.

What that evidence does not deliver is the felt payoff. A 2025 systematic review and meta-analysis of NMN and nicotinamide riboside found no reliable improvement in skeletal muscle mass or function when trials were pooled 5. The most-cited positive downstream result — improved muscle insulin sensitivity in prediabetic women 6 — is narrow and contested. The softer signals that exist, such as maintained walking speed and better sleep quality in older adults 7, are small and partly subjective. The honest sentence is the one this whole site is built around: raising NAD+ is the proven part; feeling different is not.

So when ProHealth's product page says NMN Pro "targets all 12 hallmarks of aging," treat that as a mechanism story, not a trial result. No NMN product has been shown in humans to move twelve hallmarks of aging, and the recent clinical overview of NAD+ interventions is explicit that optimal dose, route and frequency all still need large-scale study 8.

The lab report: better than the category, narrower than the badge

This is where ProHealth earns real credit, so let us be specific about what we found.

Behind the "View Certificate of Authenticity" link on the NMN Pro 500 page is an actual document, and it is a good one: an analytical test report from Brighton Laboratory, an ISO/IEC 17025-accredited lab, for sample "NMN Pro 500 (30 Capsules)," lot 2509142, received October 2025 and issued November 2025. The same report remained linked on October 15, 2026. NMN by HPLC, claim ≥500 mg per capsule, result 513.21 mg. That is product-specific, lot-specific, dated November 2025, and it over-delivers slightly on the label. 12 Most NMN sellers publish nothing of the kind, and this is the single strongest reason to take the brand seriously — third-party verification is the buying factor that actually varies between products, as we argue in best NMN supplements.

Two honest caveats sit next to it. The page badges the product as "Triple Lab Tested" and says every product "is tested three times by independent 3rd-party labs," but the document published behind that badge is one report, from one lab, covering one analyte — NMN potency. There are no heavy-metal results and no microbiological results on it. Testing may well happen three times; what a reader can verify is one test. And the link is labeled a "Certificate of Authenticity" while the document is an analytical test report. Those are small things, but this is a brand whose whole pitch is that you can check it, so the checkable part should match the badge.

Strength of evidence

  • Oral NMN raises blood NAD+Strong evidence

    Independent randomized and controlled human trials, not the manufacturer's own study.

  • NMN Pro 500 contains the milligrams claimedStrong evidence

    Lot 2509142, ISO/IEC 17025 lab, 513.21 mg against a 500 mg claim, issued November 2025.

  • Uthever beats unbranded NMNNone evidence

    No published head-to-head human comparison.

  • Reversing biological age by 12 yearsNone evidence

    The cited trial measured a serum NAD+/NADH ratio and no aging clock of any kind.

  • Energy, strength or anti-aging in healthy usersWeak evidence

    A 2025 meta-analysis found no reliable muscle benefit for NMN or NR.

  • NAD+ injection or nasal spray working fasterNone evidence

    The human record for parenteral NAD+ is a small infusion pharmacokinetic pilot, not an outcome trial.

The capsule's chemistry and paperwork are well supported; the age-reversal line and the prescription routes are not.

Two products to be careful with

Our original August review also found prescription products under a "Medical Prescription" header on the storefront:

  • NAD+ Injection, 10 mL at 100 mg/mL (1,000 mg per vial), compounded by a US-licensed pharmacy, listed at $349 with a first-month price of $244.30.
  • NAD+ Nasal Spray, 300 mg/mL, listed at $175 with a first-month price of $122.50.

Those August prescription prices are historical listings, not a current treatment quote. Both were marketed on speed: the injection "delivers benefits faster than other methods," the spray gives "cellular energy in seconds." Neither claim has a placebo-controlled human trial behind it. One early human study of parenteral NAD+ was a pilot that tracked the plasma and urine NAD+ metabolome during a six-hour intravenous infusion in a handful of people 9 — a pharmacokinetic look at where the molecule goes, not a test of whether anyone felt or functioned better. Intranasal NAD+ is thinner still. We lay out both routes in NAD+ injections: what the evidence shows and NAD+ nasal spray evidence, and the infusion route in NAD+ IV therapy evidence.

The injection page does carry a reference list, which is more than most sellers offer. But of the products on this page, the oral capsule is the one with human randomized trials behind it and the injection is the one priced five times higher. A buyer who trusts the brand because of the capsule's lab report should not carry that trust across to the syringe: the evidence does not transfer between routes, and on this storefront the price runs in the opposite direction from the evidence.

Where ProHealth is unusually straight with you

Credit where it is due, because it is rare. On the NMN collection page, in an FAQ that most brands would use to sell the upgrade, ProHealth writes that only NMN capsules have been used in human clinical studies, that a sublingual or powdered form might theoretically start absorption earlier but "nobody has data to compare the different forms," and that "liposomal NMN absorption hasn't been tested."

That is the brand telling you, on the page where it sells liposomal NMN, that the liposomal claim is untested. We have made the same argument about the format premium in liposomal NAD+ evidence and sublingual NMN vs capsules, and it is genuinely unusual to see a seller say it first.

Is ProHealth Longevity worth it?

Put it together plainly:

  • What you are reliably buying: an NMN capsule with a published report for a tested lot that delivers the milligrams it claims, from a seller that publishes the report, at $42.95 for 30 servings of 500 mg — roughly $1.43 a day at one capsule daily. Oral NMN at that dose will very likely raise your blood NAD+ 23.
  • What you are not buying: proof of the "12 years" claim, which the cited study never measured; proof that Uthever outperforms unbranded NMN, which no head-to-head trial has tested; or proven improvements in energy, strength or aging, which pooled trials do not support 5.
  • What to avoid carrying over: the confidence the capsule's paperwork earns does not extend to the prescription injection or the nasal spray on the same site.

The fair verdict: if you want an NMN capsule whose milligrams are independently verified and whose seller will show you the paperwork, ProHealth Longevity is a defensible pick, and its published lot report is real evidence you can check. Just buy it for the lab report, not for the "clinically studied" line, because that line rests on a 66-person study written by the ingredient's manufacturer that never measured biological age at all.

Bottom line

ProHealth Longevity does the two things this category almost never does: it names its raw material and it publishes a product-specific, accredited lab report showing 513.21 mg of NMN against a 500 mg claim. That is real, and it is why the brand deserves its reputation. What does not survive reading is the story wrapped around it — a single manufacturer-authored trial in 66 people, measuring a serum ratio that also rose 14.3% in the placebo arm, converted on the product page into "reversing biological age by 12 years," a quantity the paper never measured. The earlier prescription injection and nasal-spray listings also had less human outcome evidence than the oral precursor literature. Buy the capsule for the certificate; discount the rest.

To compare it on evidence rather than marketing, see best NMN supplements and best NAD+ supplements; for other brands read on the same terms, see our Tru Niagen review, Renue By Science review, Wonderfeel Youngr review and Qualia NAD+ review; for dosing, the NAD+ dosage guide and NMN dosage by weight; and for the underlying science, the NAD+ therapy evidence pillar and the NAD+ rankings hub.

This is consumer education, not medical advice. NMN is a dietary supplement, not an FDA-approved drug, and prescription NAD+ products require a clinician. If you are pregnant, nursing, taking medication or managing a medical condition, talk to a clinician first.

Frequently asked questions

Is ProHealth Longevity's NMN legitimate?

The chemistry is. Rechecked October 15, 2026, the certificate linked from ProHealth's NMN Pro 500 page is an analytical test report from Brighton Laboratory, an ISO/IEC 17025-accredited lab, for lot 2509142, showing 513.21 mg of NMN per capsule against a 500 mg label claim, issued November 2025. That is a product-specific verification for the tested lot, and most NMN sellers publish nothing comparable. What is weaker is the marketing around it, not the powder in the bottle.

Is Uthever NMN really 'clinically studied'?

There is one study, and its limits matter. The 2022 trial in Frontiers in Aging enrolled 66 adults aged 40 to 65 for 60 days at 300 mg a day; it has a single author whose stated affiliation is Effepharm, the company that manufactures Uthever NMN. It measured the serum NAD+/NADH ratio, which rose 38% in the Uthever group — and 14.3% in the placebo group. So 'clinically studied' is accurate as far as it goes, but it means one manufacturer-run study in 66 people, not an independent evidence base.

Does ProHealth's NMN really reverse biological age by 12 years?

No — and the study it cites did not test that. The Uthever trial measured a serum NAD+/NADH ratio, an SF-36 quality-of-life score and HOMA-IR. It contains no epigenetic clock, no aging biomarker panel, and no biological-age endpoint of any kind. The '12 years' figure is an inference added on the product page, not a result reported in the paper. Raising an NAD+ measure is the proven part; changing how old you are biologically has not been shown for any NMN product in humans.

References

  1. Huang H (2022). A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults. Frontiers in Aging. https://pubmed.ncbi.nlm.nih.gov/35821806/
  2. Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
  3. Okabe K, Yaku K, Uchida Y, et al. (2022). Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Frontiers in Nutrition. https://pubmed.ncbi.nlm.nih.gov/35479740/
  4. Irie J, Inagaki E, Fujita M, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. https://pubmed.ncbi.nlm.nih.gov/31685720/
  5. Prokopidis K, Moriarty F, Bahat G, et al. (2025). The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle. https://pubmed.ncbi.nlm.nih.gov/40275690/
  6. Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. https://pubmed.ncbi.nlm.nih.gov/33888596/
  7. Morifuji M, Higashi S, Ebihara S, Nagata M (2024). Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience. https://pubmed.ncbi.nlm.nih.gov/38789831/
  8. Zhang J, Wang HL, Lautrup S, et al. (2025). Emerging strategies, applications and challenges of targeting NAD+ in the clinic. Nature Aging. https://pubmed.ncbi.nlm.nih.gov/40926126/
  9. Grant R, Berg J, Mestayer R, et al. (2019). A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+. Frontiers in Aging Neuroscience. https://pubmed.ncbi.nlm.nih.gov/31572171/
  10. ProHealth Longevity (2026). NMN Pro 500 offer, serving size and subscription terms. ProHealth Longevity website.
  11. ProHealth Longevity (2026). Return policy and bulk/multipack limitations. ProHealth Longevity website.
  12. Brighton Laboratory (2025). NMN Pro 500, lot 2509142, analytical test report. Brighton Laboratory. https://cdn.shopify.com/s/files/1/0206/3076/5668/files/PH583_-_COA_Brighton_LOT_2509142_2025-11-03.pdf?v=1762970687

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.